MFN2 Antikörper (Cytoplasmic Domain)
Kurzübersicht für MFN2 Antikörper (Cytoplasmic Domain) (ABIN1821691)
Target
Alle MFN2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Cytoplasmic Domain
-
Spezifität
- Human Mitofusin-2. Species Crossreactivity: Rat. Species sequence homology: mouse (100 % ).
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Synthetic linear peptide corresponding to the cytoplasmic domain of human Mfn2 (KLH).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Approved: WB (0.5 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7.4, 150 mM sodium chloride, 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
-
- MFN2 (Mitofusin 2 (MFN2))
-
Andere Bezeichnung
- Mitofusin 2 / MFN2
-
Hintergrund
-
Name/Gene ID: MFN2
Synonyms: MFN2, CMT2A2, CMT2A, CPRP1, Hyperplasia suppressor, MARF, Mitofusin 2, HSG, Transmembrane GTPase MFN2, KIAA0214, Mitofusin-2 -
Gen-ID
- 9927
-
Pathways
- Skeletal Muscle Fiber Development
Target
-